Provectus Biopharmaceuticals - Delisted OTC Stock
Provectus Biopharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Provectus Biopharmaceutica was actively traded.
Valuation
Check how we calculate scores
Provectus Biopharmaceutica Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Provectus Biopharmaceutica market risk premium is the additional return an investor will receive from holding Provectus Biopharmaceutica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Provectus Biopharmaceutica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Provectus Biopharmaceutica's alpha and beta are two of the key measurements used to evaluate Provectus Biopharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.0637 | |||
| Jensen Alpha | 0.8903 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0774 |
View Provectus Biopharmaceutica Related Equities
| Risk & Return | Correlation |
Provectus Biopharmaceutica Corporate Directors
Provectus Biopharmaceutica corporate directors refer to members of a Provectus Biopharmaceutica board of directors. The board of directors generally takes responsibility for the Provectus Biopharmaceutica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Provectus Biopharmaceutica's board members must vote for the resolution. The Provectus Biopharmaceutica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Alfred Smith | Independent Director | Profile | |
| Bruce Horowitz | COO Director | Profile | |
| Jan Koe | Independent Director | Profile | |
| John Lacey | Director | Profile |
Still Interested in Provectus Biopharmaceuticals?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Provectus OTC Stock
If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |